Product Description
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Injection,Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Nakhia Impex LLC
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
![Map of Global Clinical Trials for HA-35](https://pryzm-maps.s3.us-west-2.amazonaws.com/666666current_maps.png)
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 1: Hepatitis, Alcoholic|Hepatitis A|Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
NCT05018481 | P1 |
Recruiting |
Hepatitis A|Hepatitis, Alcoholic |
2025-10-01 |
|
NCT05025865 | P1 |
Recruiting |
Healthy Volunteers |
2025-10-01 |
|
HSHN005 | N/A |
Enrolling by invitation |
Fibromyalgia|Chronic Pain|Myofascial Pain Syndromes |
2024-10-30 |
|
HUI0001 | N/A |
Recruiting |
Inflammation|Dermatitis |
2024-05-01 |